Replication of enhancer-deficient amphotropic murine leukemia virus in human cells
Open Access
- 4 September 2001
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (19) , 10898-10903
- https://doi.org/10.1073/pnas.191182098
Abstract
Amphotropic murine leukemia virus (MLV) replicates in cells from various mammalian species, including humans, and is a potential contaminant in MLV vector preparations for human gene transfer studies. The generation of replication-competent virus is considered less likely with vectors that delete the viral transcription elements. This conclusion is based on data obtained in rodents, where MLV replication depends on the expression of viral genes under the control of 75-bp enhancer elements in the long terminal repeat. We demonstrate here that in some human cells replication of amphotropic MLV is possible in the absence of these enhancer elements. Replication of the enhancer-deficient virus MLV-(MOA)ΔE is observed in selected human sarcoma and B lymphoma lines and proceeds at a lower rate than that of the intact virus. No insertion of a foreign promoter or enhancer into the long terminal repeat was detected. Our data suggest the presence of a secondary enhancer element within the MLV provirus that can in selected human cells mediate virus transcription and replication in the absence of the 75-bp U3 enhancers.Keywords
This publication has 29 references indexed in Scilit:
- Fast and sensitive silver staining of DNA in polyacrylamide gelsPublished by Elsevier ,2004
- Supplemental Guidance on Testing for Replication-Competent Retrovirus in Retroviral Vector-Based Gene Therapy Products and During Follow-up of Patients in Clinical Trials Using Retroviral VectorsHuman Gene Therapy, 2001
- Nucleotide sequence of the murine leukaemia virus amphotropicstrain 4070A integrase (IN) coding region and comparativestructural analysis of the inferred polypeptideArchiv für die gesamte Virusforschung, 1997
- The TMC Worldwide Gene Therapy Enrollment Report (June 1996). Report of TMC Development, Paris, FranceHuman Gene Therapy, 1996
- Characterization of a Replication-Competent Retrovirus Resulting from Recombination of Packaging and Vector SequencesHuman Gene Therapy, 1994
- Infection of Human Cells with Murine Amphotropic Replication-Competent RetrovirusesHuman Gene Therapy, 1993
- Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer.The Journal of Experimental Medicine, 1992
- Efficient replication and expression of murine leukemia virus with major deletions in the enhancer region of U3Virology, 1992
- Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cellsCell, 1986
- Non-function of a Moloney murine leukaemia virus regulatory sequence in F9 embryonal carcinoma cellsNature, 1984